日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

MTORC1/2 抑制作为 PIK3CA 突变癌症的治疗策略

Stephanie L Fricke, Susan N Payne, Peter F Favreau, Jeremy D Kratz, Cheri A Pasch, Tyler M Foley, Alexander E Yueh, Dana R Van De Hey, Mitchell G Depke, Demetra P Korkos, Gioia Chengcheng Sha, Rebecca A DeStefanis, Linda Clipson, Mark E Burkard, Kayla K Lemmon, Benjamin M Parsons, Paraic A Kenny, Kr

Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations

PI3K/mTOR 双重抑制对 APC 和 PIK3CA 突变结直肠癌的疗效

Tyler M Foley, Susan N Payne, Cheri A Pasch, Alex E Yueh, Dana R Van De Hey, Demetra P Korkos, Linda Clipson, Molly E Maher, Kristina A Matkowskyj, Michael A Newton, Dustin A Deming

Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K

由 H1047R 突变 PI3K 引发的结肠癌肿瘤发生

Alexander E Yueh, Susan N Payne, Alyssa A Leystra, Dana R Van De Hey, Tyler M Foley, Cheri A Pasch, Linda Clipson, Kristina A Matkowskyj, Dustin A Deming